Disclaimer: The information on this page is intended for Vaccine Recipients only.
Vaxzevria has been given ‘conditional approval’. This means that there is more evidence to come about this medicine. The European Medicines Agency will review new information on this medicine at least every year and the leaflet will be updated as necessary. During the pandemic, Vaxzevria may also be distributed in packaging with the name COVID‑19 Vaccine AstraZeneca.
Please refer to your Healthcare Provider for further information, or you can contact the AstraZeneca Medical Information team here.
If you are concerned about an adverse event, it can be reported via the Health Products Regulatory Authority website, (https://www.hpra.ie/homepage/about-us/report-an-issue/covid-19-vaccine-adverse-reaction).